BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33539249)

  • 21. Preoperative aspartate aminotransferase-to-platelet ratio index (APRI) is a predictor on postoperative outcomes of hepatocellular carcinoma.
    Cheng J; Zhao P; Liu J; Liu X; Wu X
    Medicine (Baltimore); 2016 Nov; 95(48):e5486. PubMed ID: 27902606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nomogram for prediction of the international study Group of Liver Surgery (ISGLS) grade B/C Posthepatectomy liver failure in HBV-related hepatocellular carcinoma patients: an external validation and prospective application study.
    Ye JZ; Mai RY; Guo WX; Wang YY; Ma L; Xiang BD; Cheng SQ; Li LQ
    BMC Cancer; 2020 Oct; 20(1):1036. PubMed ID: 33115425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Machine learning models in the prediction of 1-year mortality in patients with advanced hepatocellular cancer on immunotherapy: a proof-of-concept study.
    Lui TKL; Cheung KS; Leung WK
    Hepatol Int; 2022 Aug; 16(4):879-891. PubMed ID: 35779202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting overall survival of patients with hepatocellular carcinoma using a three-category method based on DNA methylation and machine learning.
    Dong RZ; Yang X; Zhang XY; Gao PT; Ke AW; Sun HC; Zhou J; Fan J; Cai JB; Shi GM
    J Cell Mol Med; 2019 May; 23(5):3369-3374. PubMed ID: 30784182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Machine-learning Approach for the Development of a Novel Predictive Model for the Diagnosis of Hepatocellular Carcinoma.
    Sato M; Morimoto K; Kajihara S; Tateishi R; Shiina S; Koike K; Yatomi Y
    Sci Rep; 2019 May; 9(1):7704. PubMed ID: 31147560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative platelet-albumin-bilirubin grades predict the prognosis of patients with hepatitis B virus-related hepatocellular carcinoma after liver resection: A retrospective study.
    Luo HM; Zhao SZ; Li C; Chen LP
    Medicine (Baltimore); 2018 Mar; 97(12):e0226. PubMed ID: 29561452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modified Child-Pugh grade
    Huang F; Gao J
    World J Gastroenterol; 2020 Feb; 26(7):749-758. PubMed ID: 32116422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Research on Predicting the Occurrence of Hepatocellular Carcinoma Based on Notch Signal-Related Genes Using Machine Learning Algorithms.
    Zhou D; Cao S; Xie H
    Turk J Gastroenterol; 2023 Jul; 34(7):760-770. PubMed ID: 37051625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of various approaches to combine logistic regression with genetic algorithms in survival prediction of hepatocellular carcinoma.
    Książek W; Gandor M; Pławiak P
    Comput Biol Med; 2021 Jul; 134():104431. PubMed ID: 34015670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A retrospective pilot study to examine the potential of aspartate aminotransferase to alanine aminotransferase ratio as a predictor of postoperative acute kidney injury in patients with hepatocellular carcinoma.
    Xu J; Xia Y; Li S; Cheng X; Hu S; Gao Y; Zhou X; Wang G; Zheng Q
    Ann Clin Biochem; 2019 May; 56(3):357-366. PubMed ID: 30453754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative Prediction for Early Recurrence Can Be as Accurate as Postoperative Assessment in Single Hepatocellular Carcinoma Patients.
    Cha DI; Jang KM; Kim SH; Kim YK; Kim H; Ahn SH
    Korean J Radiol; 2020 Apr; 21(4):402-412. PubMed ID: 32193888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Machine-Learning-Based Clinical Biomarker Using Cell-Free DNA for Hepatocellular Carcinoma (HCC).
    Lee T; Rawding PA; Bu J; Hyun S; Rou W; Jeon H; Kim S; Lee B; Kubiatowicz LJ; Kim D; Hong S; Eun H
    Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma.
    Wang ZX; Jiang CP; Cao Y; Zhang G; Chen WB; Ding YT
    Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):178-85. PubMed ID: 25865691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative Aspartate Aminotransferase to White Blood Cell Count Ratio Predicting Postoperative Outcomes of Hepatocellular Carcinoma.
    Liao W; Wang Y; Liao Y; He S; Jin J
    Medicine (Baltimore); 2016 Apr; 95(14):e3345. PubMed ID: 27057915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion After R0 Liver Resection: A Large-Scale, Multicenter Study.
    Zhang XP; Wang K; Wei XB; Li LQ; Sun HC; Wen TF; Chai ZT; Chen ZH; Shi J; Guo WX; Xie D; Cong WM; Wu MC; Lau WY; Cheng SQ
    Oncologist; 2019 Dec; 24(12):e1476-e1488. PubMed ID: 31138726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
    Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
    World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is serum alpha-fetoprotein useful for predicting recurrence and mortality specific to hepatocellular carcinoma after hepatectomy? A test based on propensity scores and competing risks analysis.
    Shim JH; Yoon DL; Han S; Lee YJ; Lee SG; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS
    Ann Surg Oncol; 2012 Nov; 19(12):3687-96. PubMed ID: 22644512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma.
    Mazzaferro V; Sposito C; Zhou J; Pinna AD; De Carlis L; Fan J; Cescon M; Di Sandro S; Yi-Feng H; Lauterio A; Bongini M; Cucchetti A
    Gastroenterology; 2018 Jan; 154(1):128-139. PubMed ID: 28989060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting the Risk Factors of Second Primary Cancer in Patients with Hepatocellular Carcinoma.
    Liao HH; Chang CC; Wang YX; Cheewakriangkrai C
    Stud Health Technol Inform; 2022 Jan; 289():93-96. PubMed ID: 35062100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Examinations of Factors Influencing Survival of Liver Transplantation for Hepatocellular Carcinoma: A Single-Center Experience From Budapest.
    Piros L; Fehérvári I; Görög D; Nemes B; Szabó J; Gerlei Z; Végső G; Kóbori L; Máthé Z
    Transplant Proc; 2015 Sep; 47(7):2201-6. PubMed ID: 26361680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.